The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT
暂无分享,去创建一个
Kyoungjune Pak | Keunyoung Kim | Kyoungjune Pak | Seong-Jang Kim | Keunyoung Kim | I. Kim | Bum Soo Kim | In Joo Kim | Seong Jang Kim | Hyun Yeol Nam | Man Soo Yun | Hyun-Yeol Nam | B. Kim | M. Yun
[1] John P A Ioannidis,et al. F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis , 2008 .
[2] R. Coleman,et al. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[3] Jeong-Won Lee,et al. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. , 2009, Gynecologic oncology.
[4] H. Dittmann,et al. Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Quynh-Thu Le,et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[6] A. Alavi,et al. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. , 2002, Journal of the American Academy of Dermatology.
[7] George Fountzilas,et al. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. , 2004, International journal of radiation oncology, biology, physics.
[8] T. Yen,et al. Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value. , 2009, Oral oncology.
[9] K. Hatch,et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. , 1991, Gynecologic oncology.
[10] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[11] L. Adler,et al. Positron E mission T omography f or E valuating P ara-aortic Nodal M etastasis i n L ocally A dvanced C ervical C ancer Before S urgical S taging: A S urgicopathologi c S tudy , 1999 .
[12] P. Grigsby,et al. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. , 2002, International journal of radiation oncology, biology, physics.
[13] R. Coleman,et al. Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer , 2004 .
[14] Byung-Joo Lee,et al. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy , 2010, Acta oncologica.
[15] L. Kong,et al. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma , 2010, Journal of Cancer Research and Clinical Oncology.
[16] Scott T. Grafton,et al. PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.
[17] S S Gambhir,et al. A tabulated summary of the FDG PET literature. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] P. Rubin,et al. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04). , 2002, International journal of radiation oncology, biology, physics.
[19] J. Ioannidis,et al. F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma : A Meta-analysis , 2008 .
[20] H. Dittmann,et al. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? , 2006, European journal of nuclear medicine and molecular imaging.
[21] P. Grigsby,et al. The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival , 2007, Cancer.
[22] Farrokh Dehdashti,et al. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] Jeffrey D Bradley,et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. , 2002, International journal of radiation oncology, biology, physics.
[24] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[25] S. Larson,et al. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. , 2007, Gynecologic oncology.
[26] A. Jena,et al. Magnetic resonance imaging in carcinoma cervix--does it have a prognostic relevance. , 2005, Journal of cancer research and therapeutics.
[27] R. Hustinx,et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose , 1996, European Journal of Nuclear Medicine.